Dr. Diana Nicole Spell, MBA, MD

Dr. Spell practices at Johns Hopkins Surgery Centers - White Marsh in Nottingham, Maryland.

Dr. Spell's NPI, 1285052803, was assigned on April 1, 2014. Dr. Spell graduated from Brody School of Medicine at East Carolina University in 2014. Dr. Spell holds Maryland license D0085372.

Dr. Spell's primary practice is Johns Hopkins Surgery Centers - White Marsh, at 4924 Campbell Blvd Suite 250, Nottingham, MD 21236. The practice phone is (410) 321-1124.

Dr. Spell's primary practice is Johns Hopkins Surgery Centers - White Marsh in Nottingham, Maryland. Dr. Spell is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins Community Physicians. Dmand AI also links Dr. Spell to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spell practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Spell's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Spell is licensed in Maryland.

CMS data shows 1,534 Medicare services from Dr. Spell across 17 procedure codes in 2024, for 282 Medicare patients. Medicare paid $88,020 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Spell in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spell's median patient age at 64, with 62% women.

In 2024, Dr. Spell wrote 2,113 Medicare Part D claims for 180 patients. 88% of them were for generic drugs. CMS names the drug for 1,572 of them, across 50 drugs with 11 or more claims each, at $180,837 in total drug cost. In 2023, CMS named 826 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Spell for performance year 2024, reported as part of a group. Dr. Spell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Spell as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Spell from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $13.

Dr. Spell graduated from Brody School of Medicine at East Carolina University in 2014.